Effect of simvastatin for chronic glomerulonephritis

Effect of simvastatin for chronic glomerulonephritis - Effect of simvastatin for chronic glomerulonephritis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-C000000361

Enrollment

Registered

2006-03-22

Start date

2002-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic glomerulonephritis

Interventions

simvastatin 10mg/day for 12 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with IgA nephritis, membranous nephropathy, focal glomerular sclerosis or lupus nephritis 2. Patients with hyperlipidemia

Exclusion criteria

Exclusion criteria: 1. Patients with other lipid-lowering agents 2. Patients with serum creatinine level higher than 1.6mg/dl

Design outcomes

Primary

Measure	Time frame
Amount of proteinuria after administration of simvastatin for 12 weeks	—

Secondary

Measure	Time frame
Renal function and immunological findings after administration of simvastatin for 12 weeks	—

Countries

Japan

Contacts

Public ContactHiroko Kanda

University of Tokyo Depertment of Allergy and Rheumatology

hkanda-tky@umin.ac.jp03-3815-5411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026